1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Genotyping Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Product (Instruments, Reagents
& Kits, Software and Services)
5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
5.2.3. By Application (Pharmacogenomics, Diagnostics
and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics
and Research Laboratories, Academic Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3.
Product Market Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End Use
5.3.5. By Region
6. North America Genotyping
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product (Instruments, Reagents & Kits, Software
and Services)
6.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
6.2.3. By Application
(Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural
Biotechnology, Animal Genetics, Others)
6.2.4. By End Use
(Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research
Laboratories, Academic Institutes, Others)
6.2.5. By Country
6.3.
North America: Country Analysis
6.3.1. United States Genotyping
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Application
6.3.1.2.4.
By End Use
6.3.2. Canada Genotyping Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Application
6.3.2.2.4.
By End Use
6.3.3. Mexico Genotyping
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Application
6.3.3.2.4.
By End Use
7. Europe Genotyping Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Product (Instruments, Reagents & Kits, Software
and Services)
7.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
7.2.3. By Application
(Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural
Biotechnology, Animal Genetics, Others)
7.2.4. By End Use
(Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research
Laboratories, Academic Institutes, Others)
7.2.5. By Country
7.3.
Europe: Country Analysis
7.3.1. Germany Genotyping Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Application
7.3.1.2.4.
By End Use
7.3.2. United Kingdom Genotyping
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Application
7.3.2.2.4.
By End Use
7.3.3. France Genotyping Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Application
7.3.3.2.4.
By End Use
7.3.4. Italy Genotyping Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Application
7.3.4.2.4.
By End Use
7.3.5. Spain Genotyping Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Application
7.3.5.2.4.
By End Use
8. Asia-Pacific Genotyping
Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Product (Instruments, Reagents & Kits, Software
and Services)
8.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
8.2.3. By Application
(Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural
Biotechnology, Animal Genetics, Others)
8.2.4. By End Use
(Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research
Laboratories, Academic Institutes, Others)
8.2.5. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Genotyping Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Application
8.3.1.2.4.
By End Use
8.3.2. Japan Genotyping Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Application
8.3.2.2.4.
By End Use
8.3.3. India Genotyping Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Application
8.3.3.2.4.
By End Use
8.3.4. Australia Genotyping
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Application
8.3.4.2.4.
By End Use
8.3.5. South Korea Genotyping
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Application
8.3.5.2.4.
By End Use
9. South America Genotyping
Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Product (Instruments, Reagents & Kits, Software
and Services)
9.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
9.2.3. By Application
(Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural
Biotechnology, Animal Genetics, Others)
9.2.4. By End Use
(Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research
Laboratories, Academic Institutes, Others)
9.2.5. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Genotyping Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Application
9.3.1.2.4.
By End Use
9.3.2. Argentina Genotyping
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Application
9.3.2.2.4.
By End Use
9.3.3. Colombia Genotyping Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Application
9.3.3.2.4.
By End Use
10. Middle East and
Africa Genotyping Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product (Instruments, Reagents & Kits, Software
and Services)
10.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays,
Sequencing, Mass Spectrometry, Others)
10.2.3. By Application
(Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology,
Animal Genetics, Others)
10.2.4. By End Use
(Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research
Laboratories, Academic Institutes, Others)
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Genotyping
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Application
10.3.1.2.4.
By End Use
10.3.2. Saudi Arabia Genotyping
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Application
10.3.2.2.4.
By End Use
10.3.3. UAE Genotyping Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Application
10.3.3.2.4.
By End Use
10.3.4. Kuwait Genotyping Market Outlook
10.3.4.1. Market Size &
Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share &
Forecast
10.3.4.2.1.
By Product
10.3.4.2.2.
By Technology
10.3.4.2.3.
By Application
10.3.4.2.4.
By End Use
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Porter’s Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1.
Thermo Fisher Scientific Inc
14.6.2.
Illumina Inc
14.6.3.
QIAGEN N.V.
14.6.4.
F Hoffmann-La Roche AG
14.6.5.
Danaher Corp
14.6.6.
Agilent Technologies Co Ltd
14.6.7.
Eurofins Scientific Inc
14.6.8.
GE Healthcare Inc
14.6.9.
Bio-Rad Laboratories Inc
15. Strategic
Recommendations
16.
About Us
& Disclaimer